Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Cusi

Showing results (41-50 of 189) with videos related to

Pageof 19
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|February 15, 2007
Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetesKenneth Cusi, Sangeeta Kashyap, Amalia Gastaldelli, et al.
Hepatology (Baltimore, Md.)|December 18, 2018
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver DiseaseReenam S Khan, Fernando Bril, Kenneth Cusi, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 20, 2019
Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancyMaryam Sattari, Fernando Bril, Robert Egerman, et al.
Journal of Hepatology|October 8, 2019
Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitisFernando Bril, Diana Barb, Romina Lomonaco, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2014
Healthcare transition from pediatric to adult medical homes in diabetes mellitusJ Rick Turner, Desmond A Schatz, Kenneth Cusi, et al.
Journal of Clinical Lipidology|April 17, 2022
JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular RiskKathleen L Wyne, Sheldon E Litwin, Kenneth Cusi, et al.
Journal of the Cardiometabolic Syndrome|November 6, 2008
Chronic low-dose lipid infusion in healthy patients induces markers of endothelial activation independent of its metabolic effectsSangeeta R Kashyap, Renata Belfort, Eugenio Cersosimo, et al.
Metabolism: Clinical and Experimental|February 12, 2011
Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivoShaoyun Wang, Amrita Kamat, Pablo Pergola, et al.
Investigative Radiology|May 18, 2007
Contrast-enhanced first-pass myocardial perfusion magnetic resonance imaging with parallel acquisition at 3.0 TeslaChun Ruan, Scott H Yang, Kenneth Cusi, et al.
The Lancet. Diabetes & Endocrinology|April 25, 2022
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trialAmalia Gastaldelli, Kenneth Cusi, Laura Fernández Landó, et al.
Pageof 19

Showing results (41-50 of 189) with videos related to

Sort By:
Pageof 19
American Journal of Physiology. Endocrinology and Metabolism|February 15, 2007
Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetesKenneth Cusi, Sangeeta Kashyap, Amalia Gastaldelli, et al.
Hepatology (Baltimore, Md.)|December 18, 2018
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver DiseaseReenam S Khan, Fernando Bril, Kenneth Cusi, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 20, 2019
Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancyMaryam Sattari, Fernando Bril, Robert Egerman, et al.
Journal of Hepatology|October 8, 2019
Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitisFernando Bril, Diana Barb, Romina Lomonaco, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2014
Healthcare transition from pediatric to adult medical homes in diabetes mellitusJ Rick Turner, Desmond A Schatz, Kenneth Cusi, et al.
Journal of Clinical Lipidology|April 17, 2022
JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular RiskKathleen L Wyne, Sheldon E Litwin, Kenneth Cusi, et al.
Journal of the Cardiometabolic Syndrome|November 6, 2008
Chronic low-dose lipid infusion in healthy patients induces markers of endothelial activation independent of its metabolic effectsSangeeta R Kashyap, Renata Belfort, Eugenio Cersosimo, et al.
Metabolism: Clinical and Experimental|February 12, 2011
Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivoShaoyun Wang, Amrita Kamat, Pablo Pergola, et al.
Investigative Radiology|May 18, 2007
Contrast-enhanced first-pass myocardial perfusion magnetic resonance imaging with parallel acquisition at 3.0 TeslaChun Ruan, Scott H Yang, Kenneth Cusi, et al.
The Lancet. Diabetes & Endocrinology|April 25, 2022
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trialAmalia Gastaldelli, Kenneth Cusi, Laura Fernández Landó, et al.
Pageof 19